Literature DB >> 18056447

Traf1 induction and protection from tumor necrosis factor by nuclear factor-kappaB p65 is independent of serine 536 phosphorylation.

Carl Y Sasaki1, Colin F Slemenda, Paritosh Ghosh, Theresa J Barberi, Dan L Longo.   

Abstract

Abnormal nuclear factor-kappaB (NF-kappaB) signaling has been attributed to the initiation and progression of cancer. Posttranslational modification of p65 facilitates optimal NF-kappaB signaling after activation. Here, we show that the phosphorylation of serine 536 was required for p65-mediated transcription and I kappa B alpha expression in fibroblasts. Furthermore, tumor necrosis factor (TNF) treatment slightly induced p65 phosphorylation, and both unphosphorylated and phosphorylated p65 translocated into the nucleus. The phosphorylation of serine 536 was not required for p65-mediated protection from TNF cytotoxicity and Traf1 induction in fibroblasts. Also, the corecruitment of p65 and RNA polymerase II to the Traf1 enhancer region did not require p65 phosphorylation. However, the corecruitment of p65 and RNA polymerase II to the Csf2 promoter required the phosphorylation of serine 536. These findings suggested that the requirement of serine phosphorylation at residue 536 and the distance between the NF-kappaB response element and the start of transcription may influence which genes will be transcribed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18056447      PMCID: PMC2408918          DOI: 10.1158/0008-5472.CAN-07-0922

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  42 in total

Review 1.  Circuitry of nuclear factor kappaB signaling.

Authors:  Alexander Hoffmann; David Baltimore
Journal:  Immunol Rev       Date:  2006-04       Impact factor: 12.988

2.  Transcription regulation from a TATA and INR-less promoter: spatial segregation of promoter function.

Authors:  Anuja A George; Manish Sharma; Badri N Singh; Naresh C Sahoo; Kanury Vs Rao
Journal:  EMBO J       Date:  2006-01-26       Impact factor: 11.598

Review 3.  Transcriptional regulation via the NF-kappaB signaling module.

Authors:  A Hoffmann; G Natoli; G Ghosh
Journal:  Oncogene       Date:  2006-10-30       Impact factor: 9.867

Review 4.  IKK/NF-kappaB signaling: balancing life and death--a new approach to cancer therapy.

Authors:  Jun-Li Luo; Hideaki Kamata; Michael Karin
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

5.  Cell cycle and developmental regulations of replication factors in mouse embryonic stem cells.

Authors:  Hiroko Fujii-Yamamoto; Jung Min Kim; Ken-ichi Arai; Hisao Masai
Journal:  J Biol Chem       Date:  2005-01-19       Impact factor: 5.157

6.  NF-kappaB RelA phosphorylation regulates RelA acetylation.

Authors:  Lin-Feng Chen; Samuel A Williams; Yajun Mu; Hiroyasu Nakano; James M Duerr; Leonard Buckbinder; Warner C Greene
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

7.  Mechanism of action of a distal NF-kappaB-dependent enhancer.

Authors:  Belete Teferedegne; Myesha R Green; Zhu Guo; Jeremy M Boss
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

8.  Phosphorylation of RelA/p65 on serine 536 defines an I{kappa}B{alpha}-independent NF-{kappa}B pathway.

Authors:  Carl Y Sasaki; Theresa J Barberi; Paritosh Ghosh; Dan L Longo
Journal:  J Biol Chem       Date:  2005-08-16       Impact factor: 5.157

Review 9.  Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway.

Authors:  N D Perkins
Journal:  Oncogene       Date:  2006-10-30       Impact factor: 9.867

Review 10.  Current insights into the regulation of programmed cell death by NF-kappaB.

Authors:  J Dutta; Y Fan; N Gupta; G Fan; C Gélinas
Journal:  Oncogene       Date:  2006-10-30       Impact factor: 9.867

View more
  8 in total

1.  Recruitment of RelB to the Csf2 promoter enhances RelA-mediated transcription of granulocyte-macrophage colony-stimulating factor.

Authors:  Carl Y Sasaki; Paritosh Ghosh; Dan L Longo
Journal:  J Biol Chem       Date:  2010-11-11       Impact factor: 5.157

2.  TNF-induced MAP kinase activation oscillates in time.

Authors:  Jameel Iqbal; Mone Zaidi
Journal:  Biochem Biophys Res Commun       Date:  2008-03-31       Impact factor: 3.575

3.  Transforming growth factor β1 (TGF-β1) suppresses growth of B-cell lymphoma cells by p14(ARF)-dependent regulation of mutant p53.

Authors:  Gang Chen; Paritosh Ghosh; Thomas O'Farrell; Rachel Munk; Louis J Rezanka; Carl Y Sasaki; Dan L Longo
Journal:  J Biol Chem       Date:  2012-05-23       Impact factor: 5.157

4.  Hepatocyte-specific IKKβ expression aggravates atherosclerosis development in APOE*3-Leiden mice.

Authors:  Man C Wong; Janna A van Diepen; Lihui Hu; Bruno Guigas; Hetty C de Boer; Gijs H van Puijvelde; Johan Kuiper; Anton J van Zonneveld; Steven E Shoelson; Peter J Voshol; Johannes A Romijn; Louis M Havekes; Jouke T Tamsma; Patrick C N Rensen; Pieter S Hiemstra; Jimmy F P Berbée
Journal:  Atherosclerosis       Date:  2011-07-12       Impact factor: 5.162

5.  Walleye dermal sarcoma virus rv-cyclin inhibits NF-kappaB-dependent transcription.

Authors:  Sandra L Quackenbush; Ashley Linton; Connie D Brewster; Joel Rovnak
Journal:  Virology       Date:  2009-01-26       Impact factor: 3.616

6.  Inhibitors of NF-kappaB reverse cellular invasion and target gene upregulation in an experimental model of aggressive oral squamous cell carcinoma.

Authors:  Jeff Johnson; Zonggao Shi; Yueying Liu; M Sharon Stack
Journal:  Oral Oncol       Date:  2014-02-28       Impact factor: 5.337

7.  Cerebral microvascular IL15 is a novel mediator of TNF action.

Authors:  Weihong Pan; Chuanhui Yu; Hung Hsuchou; Reas S Khan; Abba J Kastin
Journal:  J Neurochem       Date:  2009-08-31       Impact factor: 5.372

8.  Identification of 11(13)-dehydroivaxillin as a potent therapeutic agent against non-Hodgkin's lymphoma.

Authors:  Xinhua Xiao; Huiliang Li; Huizi Jin; Jin Jin; Miao Yu; Chunmin Ma; Yin Tong; Li Zhou; Hu Lei; Hanzhang Xu; Weidong Zhang; Wei Liu; Yingli Wu
Journal:  Cell Death Dis       Date:  2017-09-14       Impact factor: 8.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.